APVO
Price
$1.50
Change
-$0.10 (-6.25%)
Updated
Sep 26, 03:23 PM (EDT)
Capitalization
5.26M
KROS
Price
$15.99
Change
+$0.19 (+1.20%)
Updated
Sep 26, 04:20 PM (EDT)
Capitalization
641.72M
34 days until earnings call
Interact to see
Advertisement

APVO vs KROS

Header iconAPVO vs KROS Comparison
Open Charts APVO vs KROSBanner chart's image
Aptevo Therapeutics
Price$1.50
Change-$0.10 (-6.25%)
Volume$1K
Capitalization5.26M
Keros Therapeutics
Price$15.99
Change+$0.19 (+1.20%)
Volume$400
Capitalization641.72M
APVO vs KROS Comparison Chart in %
Loading...
APVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APVO vs. KROS commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APVO is a Hold and KROS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (APVO: $1.60 vs. KROS: $15.80)
Brand notoriety: APVO and KROS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APVO: 39% vs. KROS: 54%
Market capitalization -- APVO: $5.26M vs. KROS: $641.72M
APVO [@Biotechnology] is valued at $5.26M. KROS’s [@Biotechnology] market capitalization is $641.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APVO’s FA Score shows that 1 FA rating(s) are green whileKROS’s FA Score has 1 green FA rating(s).

  • APVO’s FA Score: 1 green, 4 red.
  • KROS’s FA Score: 1 green, 4 red.
According to our system of comparison, APVO is a better buy in the long-term than KROS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APVO’s TA Score shows that 3 TA indicator(s) are bullish while KROS’s TA Score has 4 bullish TA indicator(s).

  • APVO’s TA Score: 3 bullish, 3 bearish.
  • KROS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, APVO is a better buy in the short-term than KROS.

Price Growth

APVO (@Biotechnology) experienced а -19.19% price change this week, while KROS (@Biotechnology) price change was -1.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.17%. For the same industry, the average monthly price growth was +9.43%, and the average quarterly price growth was +55.19%.

Reported Earning Dates

KROS is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+4.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KROS($642M) has a higher market cap than APVO($5.26M). KROS has higher P/E ratio than APVO: KROS (49.38) vs APVO (0.00). KROS YTD gains are higher at: -0.190 vs. APVO (-98.144). KROS has higher annual earnings (EBITDA): 25.5M vs. APVO (-24.04M). KROS has more cash in the bank: 690M vs. APVO (9.41M). APVO has less debt than KROS: APVO (4.21M) vs KROS (18M). KROS has higher revenues than APVO: KROS (233M) vs APVO (0).
APVOKROSAPVO / KROS
Capitalization5.26M642M1%
EBITDA-24.04M25.5M-94%
Gain YTD-98.144-0.19051,788%
P/E Ratio0.0049.380%
Revenue0233M-
Total Cash9.41M690M1%
Total Debt4.21M18M23%
FUNDAMENTALS RATINGS
APVO: Fundamental Ratings
APVO
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
49
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APVOKROS
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 12 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
APVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PQCCX9.99N/A
N/A
PGIM Quant Solutions Mid-Cap Index R6
VLCGX17.84N/A
N/A
VALIC Company I Large Capital Growth
EPDPX12.95-0.04
-0.31%
EuroPac International Dividend Income A
RGGYX27.04-0.18
-0.66%
Victory RS Global Y
TILPX32.23-0.24
-0.74%
Nuveen Large Cap Growth Premier

APVO and

Correlation & Price change

A.I.dvisor indicates that over the last year, APVO has been loosely correlated with ENLV. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if APVO jumps, then ENLV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APVO
1D Price
Change %
APVO100%
-10.11%
ENLV - APVO
36%
Loosely correlated
-1.44%
KROS - APVO
34%
Loosely correlated
+0.32%
GNPX - APVO
33%
Loosely correlated
-10.59%
IMRX - APVO
29%
Poorly correlated
-13.33%
INO - APVO
28%
Poorly correlated
-3.57%
More

KROS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KROS has been loosely correlated with INO. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if KROS jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KROS
1D Price
Change %
KROS100%
+0.32%
INO - KROS
52%
Loosely correlated
-3.57%
ANAB - KROS
41%
Loosely correlated
-0.45%
DNLI - KROS
39%
Loosely correlated
-0.37%
XNCR - KROS
38%
Loosely correlated
-1.34%
ALT - KROS
38%
Loosely correlated
N/A
More